Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CASI Pharmaceuticals (CASI) Interest Expenses (2024 - 2025)

Historic Interest Expenses for Pharmaceuticals (CASI) over the last 2 years, with Q2 2025 value amounting to -$244000.0.

  • Pharmaceuticals' Interest Expenses fell 2842.11% to -$244000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$631000.0, marking a year-over-year decrease of 6518.32%. This contributed to the annual value of -$871000.0 for FY2024, which is 570666.67% down from last year.
  • Per Pharmaceuticals' latest filing, its Interest Expenses stood at -$244000.0 for Q2 2025, which was down 2842.11% from -$197000.0 recorded in Q1 2025.
  • Pharmaceuticals' 5-year Interest Expenses high stood at -$190000.0 for Q2 2024, and its period low was -$244000.0 during Q2 2025.